Literature DB >> 31678015

Cystic fibrosis in black African children in South Africa: a case control study.

Sandra Kwarteng Owusu1, Brenda M Morrow2, Debbie White3, Susan Klugman3, Aneesa Vanker4, Diane Gray4, Marco Zampoli5.   

Abstract

BACKGROUND: Cystic fibrosis (CF) is described more commonly in Caucasian populations in whom p.Phe508del is the most common mutation. There is a paucity of data of CF in black African children. The aim of this study was to describe and compare the presentation and outcomes of black African children with CF to those with p.Phe508del genotype.
METHODS: A retrospective case-controlled study was conducted from January 2000 - March 2018 of children with CF attending two CF centres in South Africa. Presentation, genotype, nutrition and pulmonary function outcomes of black African children were compared to matched controls with the p.Phe508del mutation.
RESULTS: Thirty-four black African children (cases) with median age of diagnosis (5.5 months, IQR 2.0-15.0) were matched to 34 controls. Among cases, 3120+1G->A CFTR mutation was most commonly identified; homozygous n=22 (64.7%) and heterozygous=7(20.5%). Compared to controls, cases at diagnosis were more malnourished and fewer presented with neonatal bowel obstruction [cases n=2 (5.9%) vs. controls n=10 (29.4%); p = 0.03]. Nutrition and pulmonary function (FEV1 in children ≥ 6 years) outcomes and changes over time from ages 3-16 years were similar in both groups; median FEV1 z-score at age 6,10 and 14 years was -0.9 (±1.5), -1.8 (±2.0) and -1.8 (±1.9) respectively for all patients. Deaths were recorded in three cases (8.8%) and one control (2.9%) (p = 0.6).
CONCLUSION: Black African children with CF were more malnourished at diagnosis, and fewer presented with neonatal bowel obstruction. Cases and controls had comparable nutritional, pulmonary function and early mortality outcomes.
Copyright © 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Black African children; Cystic Fibrosis; South Africa

Year:  2019        PMID: 31678015     DOI: 10.1016/j.jcf.2019.09.007

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  5 in total

1.  Prenatal Ultrasound Suspicion of Cystic Fibrosis in a Multiethnic Population: Is Extensive CFTR Genotyping Needed?

Authors:  Chadia Mekki; Abdel Aissat; Véronique Mirlesse; Sophie Mayer Lacrosniere; Elsa Eche; Annick Le Floch; Sandra Whalen; Cecile Prud'Homme; Christelle Remus; Benoit Funalot; Vanina Castaigne; Pascale Fanen; Alix de Becdelièvre
Journal:  Genes (Basel)       Date:  2021-04-29       Impact factor: 4.096

Review 2.  Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health.

Authors:  Yitian Zhou; Volker M Lauschke
Journal:  Hum Genet       Date:  2021-10-15       Impact factor: 5.881

Review 3.  The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery.

Authors:  Virginie Scotet; Carine L'Hostis; Claude Férec
Journal:  Genes (Basel)       Date:  2020-05-26       Impact factor: 4.096

4.  Phenotypic Presentations of Cystic Fibrosis in Children of African Descent.

Authors:  Sophie Mayer Lacrosniere; Michele Gerardin; Laurence Le Clainche-Viala; Veronique Houdouin
Journal:  Genes (Basel)       Date:  2021-03-23       Impact factor: 4.096

5.  Cystic fibrosis in South Africa: spectrum of disease and determinants of outcome.

Authors:  Marco Zampoli; Janine Verstraete; Marlize Frauendorf; Reshma Kassanjee; Lesley Workman; Brenda M Morrow; Heather J Zar
Journal:  ERJ Open Res       Date:  2021-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.